$77.36
Price
$1.7B
Market Cap
48.4
P/E Ratio
8.9
Forward P/E
$1.60
EPS (TTM)
—
Dividend Yield
$271M
Cash
$624M
Total Debt
22M
Shares Out
$54.10
$99.50
52-Week Range
Institutional Ownership of ANI PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for ANI PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2018-Q3 | |||||
| SELL | EXIT | — | — | $57.30 | |
Insider Trading for ANI PHARMACEUTICALS INC
6 Months Insider Sentiment
Buy $0
Sell $3.3M
0
Buys
11
Sells
-3.3M
Net
1
Grants
Largest
$1.3M
Gassert
$751K
Walsh
$692K
Pera
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 18, 2025 | Krista Davis | SVP, CHIEF HR OFFICER | SELL | 1.6K | $82.40 | $134K |
| Dec 12, 2025 | Meredith Cook | SR. VP, GENERAL COUNSEL & SEC. | SELL | 400 | $82.32 | $33K |
| Dec 05, 2025 | Renee P Tannenbaum | Director | SELL | 1.8K | $81.15 | $146K |
| Nov 13, 2025 | Chad Gassert | SVP - CORP. DEV. & STRATEGY | SELL | 94 | $88.00 | $8K |
| Nov 13, 2025 | Patrick D Walsh | Director | SELL | 8.6K | $86.88 | $751K |
| Nov 13, 2025 | Patrick D Walsh | Director | GRANT | 3.0K | — | — |
| Nov 13, 2025 | Meredith Cook | SR. VP, GENERAL COUNSEL & SEC. | SELL | 400 | $87.27 | $35K |
| Nov 12, 2025 | Chad Gassert | SVP - CORP. DEV. & STRATEGY | SELL | 14.6K | $89.07 | $1.3M |
| Oct 13, 2025 | Meredith Cook | SR. VP, GENERAL COUNSEL & SEC. | SELL | 400 | $90.09 | $36K |
| Sep 19, 2025 | Krista Davis | SVP, CHIEF HR OFFICER | SELL | 1.0K | $98.04 | $98K |
| Sep 12, 2025 | Meredith Cook | SR. VP, GENERAL COUNSEL & SEC. | SELL | 400 | $98.42 | $39K |
| Sep 03, 2025 | Antonio R Pera | Director | SELL | 7.3K | $94.94 | $692K |